EGFR Antibody (h-R3 (Nimotuzumab)) - Azide and BSA Free, Novus Biologicals™

EGFR Domain 3

Monoclonal

Unconjugated

PBS with 0.02% Proclin 300

EGFR

Raised by humanisation of the murine antibody R3 against EGFR purified from placenta membranes and A431 tumors.

0.2 mg

Primary

Human

Purified

Flow Cytometry, Immunohistochemistry, Immunofluorescence, Blocking Assay, Neutralization

h-R3 (Nimotuzumab)

Flow Cytometry 1:10 - 1:1000, Immunohistochemistry 1:10 - 1:500, Immunofluorescence, Block/Neutralize

avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, biosimilar, biosimilars, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGFR variant III, epidermal growth factor receptor, epidermal growt

Human

Protein A purified

Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Cellular Signaling, Growth and Development, Hypoxia, Phospho Specific, Signal Transduction, Tumor Suppressors, Tyrosine Kinases

Binds to human EGFR domain III at a site distinct from antibody 7A7 (Ab00134) (Talavera et al. 2011)

Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

IgG1 κ